Home

>

Stocks

>

Camlin Fine Sciences Limited

info-icon
The current prices are delayed, login to your account for live prices
Login

Camlin Fine Sciences Limited

CAMLINFINE

BSE
NSE

Chemicals / Specialty Chemicals

Loading...

NSE / BSE (Listed 2007)

About

Camlin Fine Sciences Limited

Company Overview

Camlin Fine Sciences Ltd., formerly known as Camlin Fine Chemicals, is an Indian corporation that manufactures chemicals to improve the shelf life of food and other products, aromatic compounds, and performance chemicals. CFS has emerged as the largest producer of food antioxidants such as tert-Butylhydroquinone (TBHQ) and Butylated hydroxyanisole (BHA). It is also one of the world's leading Vanillin producers.

"As a leading global producer of antioxidants and vanillin, what makes us, Camlin Fine Sciences, unique is the extent to which we are vertically integrated." Our plant in Ravenna, one of Italy's largest chemical districts, produces the basic raw material hydroquinone and catechol. Our vertical integration capability then translates it into a wide range of downstream products like TBHQ, BHA, 4-TBC, Guaiacol, etc.

Business Segments and Products

Camlin Fine Sciences Ltd is engaged in research, development, manufacturing, commercializing, and marketing of specialty chemicals and blends. These chemicals are used in food, feed, animal and pet nutrition, and industrial products. The company's product portfolio consists of Shelf life solutions, Aroma ingredients, Performance chemicals, and Health & Wellness.

Shelf life extension solutions include antioxidant solutions which are used to increase the shelf life of oils. The Aroma vertical includes production of Vanillin and Ethyl Vanillin. Performance Chemicals consist of Guaiacol, Veratrole, TBC, and MEHQ and are used in sectors such as food flavoring, pharmaceuticals intermediate, and fragrance industry.

It has a portfolio of more than 100 natural shelf life extending products under the brand names Xtendra and NaSure. The company markets its products under the Xtendra, NaSure, Biosus, Ezential, and Adorr brand names.

Global Presence and Manufacturing

CFS has offices and manufacturing facilities in several countries, such as India, China, Italy, Brazil, Mexico, and the United States. Today, CFS has its blending facilities across the world (India, China, Mexico, USA, and Brazil). Camlin Fine Sciences sells its products through supply chain network across North, Central and South America, Europe, and Asia-Pacific.

By virtue of this vertical integration strength, Camlin Fine Sciences introduces its adorrTM vanillin range, manufactured at a state-of-the-art facility in Dahej, India, where raw materials to finished products are all produced under one roof. Catering to industries as diverse as food, fragrance, pet food, animal nutrition, petrochemicals, pharmaceuticals, agrochemicals.

Financial Performance

Sales rose 14.62% to ₹1,666.53 Crore in the year ended March 2025, as against ₹1,453.91 Crore during the previous year ended March 2024. For the full year, net loss reported to ₹139.05 Crore in the year ended March 2025, as against net loss of ₹92.75 Crore during the previous year ended March 2024.

Sales rose 16.14% to ₹437.46 Crore in the quarter ended March 2025, as against ₹376.65 Crore during the previous quarter ended March 2024. Net Loss of Camlin Fine Sciences reported to ₹0.72 Crore in the quarter ended March 2025, as against net loss of ₹77.14 Crore during the previous quarter ended March 2024.

Market Cap: ₹5,581 Crore (up 202% in 1 year) as of the latest available data. Promoter Holding: 49.1%.

Key Financial Metrics:

- Revenue (FY25): ₹1,666.53 Crore

- Net Loss (FY25): ₹139.05 Crore

- Market Cap: ₹5,581 Crore (as of latest data)

- Q4 FY25 Revenue: ₹437.46 Crore

- Q4 FY25 Net Loss: ₹0.72 Crore

Company History and Milestones

In 1984, Camlin Fine Chemicals Division was started by Camlin with the setting up of a new ultra modern plant at Tarapur, India. In 2006, Camlin Fine Chemicals demerged from the parent company and an entirely new entity was formed called Camlin Fine Sciences Ltd. In 2007, CFS was listed on the Bombay Stock Exchange. In 2011, CFS got listed on the National Stock Exchange of India.

The company entered into performance chemicals segment with the acquisition of Borregaard Italia Spa ltd in March 2011 and became one of the largest producers of di-phenols (Hydroquinone and Catechol). Having established global leadership in antioxidants, CFS moved forward in blending by setting up a unit in Tarapur, India and in Brazil in 2014.

Market Position and Competition

Camlin Fine Sciences major competitors are Privi Specialty Che, Clean Science, Vishnu Chemicals, Tanfac Industries, Tatva Chintan Pharma, Styrenix Performance, Ultramar & Pigments. "We are the world's leading integrated producer of diphenol derivatives."

In a challenging global environment marked by tariffs and geopolitical tensions, the company demonstrated resilience with satisfactory financial results, driven by strategic discontinuation of unviable operations in Europe and China. Despite facing price pressures, particularly in the vanillin market due to competition from Chinese manufacturers, the core blends segment showed significant year-on-year growth, bolstered by anticipated anti-dumping duties.

Future Outlook

"We cater to the demands of our customers by bringing innovative high-quality products to the food, petfood, fragrances, animal nutrition, rendering, aquaculture and biofuel segments as well as pharmaceutical, dyes, petrochemical, agrochemical, textile and tanning industries. CFS would be consistent in its efforts to innovate and bring science to everyday life."

The company has widened its applications for different food industries such as snacks, bakery, meat & poultry, spices & seasonings, etc. and has also tapped potential shelf life solutions in fried snacks, pet food, fishmeal, biodiesel, confectionery, animal feed.

Camlin Fine Sciences continues to strengthen its position as a global leader in specialty chemicals through strategic acquisitions, vertical integration, and continuous innovation in product development. The company's diversified product portfolio and global manufacturing footprint position it well to serve the evolving needs of its customer base across multiple industries.